Long-term Maintenance Benefits of a Pulmonary Rehabilitation Program Using a Mobile Digital Solution: a Prospective, Randomized, Controlled, Multicenter Study in a Population of COPD Patients (m-Rehab COPD)

Chronic obstructive pulmonary disease (COPD) is a public health problem: high prevalence; increasing morbidity and mortality; impact on health costs. Pulmonary rehabilitation (PR) is a multidisciplinary intervention combining exercise training, therapeutic education, psychosocial and behavioral interventions. Its effects are beneficial in the short and medium terms but are limited in time, between 6 and 12 months, for patients who do not pursue regular physical activity (PA) in post-rehabilitation and who do not adopt behavioral changes for health, by loss of motivation. Maintaining the long-term benefits acquired during a short-term PR program is therefore a major issue in the management of COPD. The recent development of remote rehabilitation is a promising approach that has been studied in few studies.

In a randomized, controlled and multicenter study, we propose to test the hypothesis that the use of a mobile telerehabilitation solution will allow COPD patients to mainain at long-term the benefits acquired during a short-temr programm and therfore improve their quality of life.

(PA) in post-rehabilitation and who do not adopt behavioral changes for health, by loss of motivation. Maintaining the long-term benefits acquired during a short-term PR program is therefore a major issue in the management of COPD. The recent development of remote rehabilitation is a promising approach that has been studied in few studies.

In a randomized, controlled and multicenter study, we propose to test the hypothesis that the use of a mobile telerehabilitation solution will allow COPD patients to mainain at long-term the benefits acquired during a short-temr programm and therfore improve their quality of life.

Study Overview

• Status: Recruiting
• Conditions: Chronic Obstructive Pulmonary Disease
• Intervention / Treatment: Other: telerehabilitation

Detailed Description

Exclusion criteria:

• Presence of contraindications for exercise training (neuromuscular disease, orthopedic cause).
• Patients with significant and unstable cardiovascular disease.
• Inability to understand and/or answer questionnaires.
• Refusal to use a smartphone or digital device.
• Unable to access an internet connection at home.

Analysis:

• The main analysis will be the univariate intention-to-treat analysis of the primary outcome.
• Secondary analyzes will include:
• Analysis with intention to treat secondary endpoints.
• Multivariate analysis of the efficiency criteria.
• Univariate and multivariate medico - economic cost - utility analyzes, with their respective sensitivity analyzes.

Protocol:

This prospective, randomized study with two parallel arms, controlled against standard chronic care will be multicentric and open.

• Patients included will be patients diagnosed with COPD who are on RR for four weeks in one of the three centers participating in the study.
• Participation in the study will be offered after verification of the eligibility criteria, during the 3rd week of the stay.
• The information note will then be provided to them.
• After obtaining consent, the volunteers will be included in the study at the start of the 4th week and randomized into two arms:
• - Experimental group of 100 patients using the M-Réhab BPCO telerehabilitation solution. The solution will be provided during the fourth and final week of RR's stay during which patients will be trained to use all of the solution's features. Patients will carry out the entire post-rehabilitation using the remote rehabilitation solution and will benefit from medical assessments by teleconsultation at 1, 3, 6 and 12 months as well as assessments at 3, 6 and 12 months by filling. electronic auto-questionnaires followed by a telephone quality control if necessary. A final evaluation at 12 months, by videoconference, will be carried out at the patient's home.
• Control group of 100 patients following usual standard chronic care. Patients will receive during the last week of stay in the center, the usual advice to continue physical activity and nutritional advice at home. The evaluations at 3, 6 and 12 months will be done by electronic filling of auto-questionnaires followed by a telephone quality control if necessary. A final evaluation at 12 months, by videoconference, will be carried out at the patient's home.

The duration of the inclusions is 18 months and the follow-up will be carried out over 12 months.

• Study Type: Interventional
• Enrollment (Estimated): 200
• Phase: Not Applicable

Contacts and Locations

• Study Contact: Name: Maurice HAYOT, MD, PhD; Phone Number: +33 467 335 908; Email: m-hayot@chu-montpellier.fr

Study Locations

• France
  • Osséja, France, 66340
    • Recruiting
    • Clinique du Souffle
    • Contact: Julie BLANC MAURIN, Dr; Phone Number: (+33)6.65.84.96.49
    • Contact: Séverine MANANDISE; Phone Number: (+33)6.65.84.96.49; Email: severine.manandise@korian.fr
  • Occitanie
    • Montpellier, Occitanie, France, 34295
      • Not yet recruiting
      • Centre hopsitalier universitaire de Montpellier
      • Contact: Maurice HAYOT, MD, PhD; Phone Number: +33 467 335 908; Email: m-hayot@chu-montpellier.fr

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 40 years to 78 years (Adult, Older Adult)
• Accepts Healthy Volunteers: No

Description

Inclusion Criteria:

• Patients diagnosed with COPD according to the GOLD (Global Initiative for Chronic Obstructive Lung Disease) creteria.
• Presence of an incompletely reversible obstructive ventilatory disorder defined by a report VEMS / CVF lower than the lower limit of normal post-bronchodilator.
• Patient on RR for four weeks in respiratory rehabilitation center.
• Aged between 40 and 78 years.

Exclusion Criteria:

• Presence of contraindications for exercise training (neuromuscular disease, orthopedic cause).
• Patients with significant and unstable cardiovascular disease.
• Inability to understand and/or answer questionnaires.
• Refusal to use a smartphone or digital device.
• Unable to access an internet connection at home.

Study Plan

How is the study designed?

Design Details

• Primary Purpose: Treatment
• Allocation: Randomized
• Interventional Model: Parallel Assignment
• Masking: None (Open Label)

Number of Arms

2

Arms and Interventions

Participant Group / Arm	Intervention / Treatment
Experimental: Telerehabilitation; Experimental group of 100 patients using the M-Réhab BPCO telerehabilitation solution. The solution will be provided during the fourth and final week of RR's stay during which patients will be trained to use all of the solution's features. Patients will carry out the entire post-rehabilitation using the remote rehabilitation solution and will benefit from medical assessments by teleconsultation at 1, 3, 6 and 12 months as well as assessments at 3, 6 and 12 months by filling. electronic auto-questionnaires followed by a telephone quality control if necessary. A final evaluation at 12 months, by videoconference, will be carried out at the patient's home.	Other: telerehabilitation; After obtaining consent, the volunteers will be included in the study at the start of the 4th week and randomized into two arms: Experimental and Control group; Other Names: Digital solution of telerehabilitation with remote connected objects
No Intervention: Standard chronic care; following usual standard chronic care. Patients will receive during the last week of stay in the center, the usual advice to continue physical activity and nutritional advice at home. The evaluations at 3, 6 and 12 months will be done by electronic filling of auto-questionnaires followed by a telephone quality control if necessary. A final evaluation at 12 months, by videoconference, will be carried out at the patient's home.

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Quality of Life of chronic obstructive pulmonary disease patients after a 1-year téléherabilitaion versus standard care program, after an initial short-term pulmonary rehabilitation program	Quality of life assessed by the Saint Georges Respiratory Questionnaire. Three scores are calculated for the components: Symptoms; Activities; Impacts. A Total SCORE is also calculated. The minimum significant difference is 4 points.	12 months

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Pre-intentional variables	Perceived risk: questionnaire focused on respiratory disease and conditioned by absence of adoption of physical activity behavior. Expectation of conséquences: questionnaire of the expected effects of Physical activity on physical health and psychological well-being. Self-efficacy: questionnaire relating to their perceived ability to perform the quantity of physical activity recommended by healthcare professionals. Intentions: determination and realization of physical activity behavior in the next months.	baseline
Post-intentional variables	planning: by a Questionnaire relating to the anticipation of the conditions to realize physical activity. self-efficacy with regard to barriers: questionnaire relating to their perceived ability to perform physical activity recommended despite the difficulties encountered. Social support:questionnaire relating to the behavior of the entourage habits: questionnaire on automatic nature of physical activity behavior.	6 months
Physical Activity behaviors.	Measured by the International Physical Activity Questionnaire as a continuous variable (MET minutes a week). MET minutes represent the amount of energy expended carrying out physical activity. walking consider to be 3.3 METS, moderate physical activity to be 4 METS and vigorous physical activity to be 8 METS.	12 months
Predictive model of physical activity behavior	Test a predictive model of physical activity behavior at 12 months in each of the two arm groups.	At 12 months

Collaborators and Investigators

• Sponsor: University Hospital, Montpellier

Publications and helpful links

General Publications

• Cox NS, Dal Corso S, Hansen H, McDonald CF, Hill CJ, Zanaboni P, Alison JA, O'Halloran P, Macdonald H, Holland AE. Telerehabilitation for chronic respiratory disease. Cochrane Database Syst Rev. 2021 Jan 29;1(1):CD013040. doi: 10.1002/14651858.CD013040.pub2.

Study record dates

Study Major Dates

• Study Start (Actual): March 10, 2022
• Primary Completion (Estimated): October 1, 2024
• Study Completion (Estimated): May 1, 2025

Study Registration Dates

• First Submitted: June 29, 2020
• First Submitted That Met QC Criteria: September 10, 2020
• First Posted (Actual): September 16, 2020

Study Record Updates

• Last Update Posted (Actual): September 14, 2023
• Last Update Submitted That Met QC Criteria: September 13, 2023
• Last Verified: September 1, 2023

More Information

Terms related to this study

• Keywords: Telemedicine; Quality of life; Telerehabilitation; Chronic obstructive pulmonary disease; Exercise training; E-health; Connected objects; Care manager
• Additional Relevant MeSH Terms: Pathologic Processes; Respiratory Tract Diseases; Disease Attributes; Chronic Disease; Lung Diseases; Lung Diseases, Obstructive; Pulmonary Disease, Chronic Obstructive
• Other Study ID Numbers: UF 9797

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No